A Look At Roche Holding's (SWX:ROG) Valuation As TIGIT And AI Pathology Progress Draw Fresh Attention [Yahoo! Finance]
ROCHE HOLDING LTD S/ADR (RHHBY)
NASDAQ:AMEX Investor Relations:
roche.com/investors.htm
Company Research
Source: Yahoo! Finance
Analytics expanding its AI pathology platform into oncology related biomarkers and trial support. See our latest analysis for Roche Holding. Roche Holding's share price has been firming, with a 30 day share price return of 7.64% and a 90 day share price return of 16.95%, taking the stock to CHF 339.4. The 1 year total shareholder return of 29% points to momentum that extends beyond the recent optimism around TIGIT and oncology related developments. If this kind of oncology driven story has your attention, it could be a good moment to broaden your watchlist with healthcare stocks that might fit a similar thesis. With Roche posting a 29% 1 year total return, trading at CHF 339.4 and sitting close to the average analyst price target, the key question is whether its oncology pipeline leaves hidden value or whether the market is already pricing in future growth. Roche Holding's most followed narrative sees fair value modestly below the current CHF 339.4 share price, framing TIGIT
Show less
Read more
Impact Snapshot
Event Time:
RHHBY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RHHBY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RHHBY alerts
High impacting ROCHE HOLDING LTD S/ADR news events
Weekly update
A roundup of the hottest topics
RHHBY
News
- Magnet Biomedicine Expands Leadership with Appointment of Nick Vlahakis, M.B.B.S., as Chief Medical Officer [Yahoo! Finance]Yahoo! Finance
- MediLink Has Signed an Additional Exclusive Licensing Agreement with Roche [Yahoo! Finance]Yahoo! Finance
- Roche (OTCMKTS:RHHBY) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.MarketBeat
- Immunotherapy and AI Biomarker Advances Might Change The Case For Investing In Roche Holding (SWX:ROG) [Yahoo! Finance]Yahoo! Finance
- Roche (OTCMKTS:RHHBY) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating.MarketBeat